The emergence of the global economy is affecting the supply chains of food and medical products, raising public health and safety concerns throughout the world. To combat the situation, governments are looking at improving regulatory systems to ensure that medical products and foods are safe regardless of where they are produced or consumed.
In the United States, the supply chain issue has drawn the attention of Congress and the Food and Drug Administration (FDA) because an estimated 80% of active pharmaceutical ingredients and 40% of finished drugs come from abroad. Food is also a concern, as it is also increasingly imported; for example, about 85% of seafood consumed in the United States is from abroad.
Mitka M. IOM Report Lays Out a Blueprint for Improving Regulatory Systems Worldwide. JAMA. 2012;307(19):2014–2016. doi:10.1001/jama.2012.4485
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: